Key result
Elevated CRP in newly diagnosed hypertension is linked to worse inflammatory and lipid profiles.
Why the study?
Although evidence suggests a relationship between inflammation and haematological and coagulatory parameters in systemic hypertension, it remains unclear whether elevated C-reactive protein is responsible for these alterations.
Does elevated C-reactive protein alter haematological, coagulatory, and inflammatory parameters compared to normal C-reactive protein in newly diagnosed systemic hypertensive patients?
Cross-Sectional (n=160)
No
Does elevated C-reactive protein alter haematological, coagulatory, and inflammatory parameters compared to normal C-reactive protein in newly diagnosed systemic hypertensive patients?
In newly diagnosed hypertensive patients, elevated CRP is associated with higher IL-6, lymphocytes, and lipid levels (triglycerides and total cholesterol), but does not drive significant general haematological or coagulatory abnormalities.
Answers are grounded in this paper and cite their sources.
Elevated CRP signals no haematological or coagulatory changes in new hypertension; leaves open inflammation's role pending larger prospective studies.
Systemic hypertension is progressively acknowledged as not just a cardiovascular condition but also one associated with systemic inflammation. In recent years, growing evidence has suggested an intricate relationship between inflammation and haematological and coagulatory parameters in systemic hypertension. Among the biomarkers of inflammation, C-reactive protein (CRP) has gathered significant attention due to its predictive value in cardiovascular diseases. However, it remains enigmatic whether elevated CRP is responsible for the alteration in haematological and coagulatory parameters in hypertension or not. Understanding these differences is critical for elucidating the role of inflammation in hypertension-associated haematological and coagulatory abnormalities. A total of 160 NDHTN were serially recruited from the Cardiac clinic of LAUTECH Teaching Hospital, Ogbomosho between May to December 2024. Medical and socio-demographic data of the participants were gathered via questionnaire, interview and retrieval from their folders. About 7 mL of blood was collected for the evaluation of haematology, coagulatory, and inflammatory biomarkers using standard procedure. The participants were categorized into two; elevated CRP; NDHTN+eCRP (n = 148) and normal CRP, NDHTN+nCRP (n = 12). Continuous and categorical data were expressed in mean standard deviation and percent respectively. Data was analyzed using SPSS version 26.1. Significant elevation in lymphocytes, IL-6, triglyceride and total cholesterol (p < 0.005) in NDHTN+eCRP. On the other hand, neutrophil and neutrophil to lymphocytes ratio was significantly elevated (p < 0.05) in NDHTN+nCRP. The findings emphasize the role of inflammation and lipid abnormalities in NDHTN, particularly in individuals with elevated CRP. CRP is not associated with significant haematology and coagulatory changes.
No takes yet. Share an insight, caveat, or question.
Oluwaseun et al. (2025) conducted a cross-sectional in Newly diagnosed systemic hypertension (NDHTN) (n=160). Elevated C-reactive protein (CRP) levels (n = 148) vs. Normal C-reactive protein (CRP) levels (n = 12) was evaluated on Haematological, coagulatory, and inflammatory parameters (lymphocytes, IL-6, triglyceride, total cholesterol, neutrophils, and neutrophil-to-lymphocyte ratio) (p=<0.005). Elevated CRP in newly diagnosed hypertension was associated with higher lymphocytes, IL-6, triglycerides, and total cholesterol, without major coagulatory changes.
Synapse has enriched 10 related papers. Consider them for comparative context: